5341 - 5350 of 9117 Results
Title
Year
-
OPENTitle: Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 4Start Page: 723End Page: 735Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261431204Best OA location URL: https://doi.org/10.1177/1877718x261431204Citation Count: 0
-
OPENTitle: A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 514Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aau6870Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7359409Citation Count: 106
-
OPENTitle: Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synucleinJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 4Start Page: 683End Page: 698Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261431108Best OA location URL: https://doi.org/10.1177/1877718x261431108Citation Count: 0
- MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset2023OPENTitle: MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onsetJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 113Issue #:Start Page: 105517End Page: 105517Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105517Citation Count: 4
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
- The Linked Clinical Trials initiative (LCT) for Parkinson's disease2018RESTRICTEDTitle: The Linked Clinical Trials initiative (LCT) for Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 307End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14175Citation Count: 20
-
RESTRICTEDTitle: Selective Small Molecule Inhibition of Poly(ADP-Ribose) Glycohydrolase (PARG)Journal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 7Issue #: 3Start Page: 563End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/cb200506tBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3306470Citation Count: 54
-
RESTRICTEDTitle: Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regenerationJournal Name: Acta BiomaterialiaPublisher: Elsevier BVVol: 38Issue #:Start Page: 44End Page: 58Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.actbio.2016.04.021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5457669Citation Count: 87
- Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017OPENTitle: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 43
- Changes in the detergent‐insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression2016RESTRICTEDTitle: Changes in the detergent‐insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progressionJournal Name: PROTEOMICSPublisher: WileyVol: 16Issue #: 23Start Page: 3042End Page: 3053Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pmic.201600057Citation Count: 104